These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9377947)

  • 1. Alpha1-antitrypsin augmentation therapy.
    Pierce JA
    Chest; 1997 Oct; 112(4):872-4. PubMed ID: 9377947
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
    Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
    Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.
    Seersholm N; Wencker M; Banik N; Viskum K; Dirksen A; Kok-Jensen A; Konietzko N
    Eur Respir J; 1997 Oct; 10(10):2260-3. PubMed ID: 9387950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Substitution therapy in alpha 1-antitrypsin deficiency].
    Konietzko N
    Pneumologie; 2001 Jan; 55(1):1-3. PubMed ID: 11236351
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: enough is enough.
    Balbi B; Ferrarotti I; Miravitlles M
    Eur Respir J; 2016 Jan; 47(1):35-8. PubMed ID: 26721962
    [No Abstract]   [Full Text] [Related]  

  • 6. alpha1-Antitrypsin deficiency . 5: intravenous augmentation therapy: current understanding.
    Stoller JK; Aboussouan LS
    Thorax; 2004 Aug; 59(8):708-12. PubMed ID: 15282394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin].
    Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
    Pneumologie; 1998 Oct; 52(10):545-52. PubMed ID: 9847632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hereditary alpha-1-antitrypsin deficiency can cause COPD. Substitution treatment seems to result in fewer infections and prolonged survival].
    Janciauskiene S
    Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3631-4, 3637-8. PubMed ID: 18193673
    [No Abstract]   [Full Text] [Related]  

  • 9. Augmentation therapy in alpha-1 antitrypsin deficiency.
    Heresi GA; Stoller JK
    Expert Opin Biol Ther; 2008 Apr; 8(4):515-26. PubMed ID: 18352854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group.
    Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
    Eur Respir J; 1998 Feb; 11(2):428-33. PubMed ID: 9551749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation therapy for alpha-1 antitrypsin deficiency--not enough evidence to support its use yet!
    McCarthy C; Dimitrov BD
    COPD; 2010 Jun; 7(3):234; author reply 235-6. PubMed ID: 20486824
    [No Abstract]   [Full Text] [Related]  

  • 12. Case detection of alpha1-antitrypsin deficiency: does it help the patient or the doctor?
    Stolk J
    Eur Respir J; 2005 Oct; 26(4):561-2. PubMed ID: 16204582
    [No Abstract]   [Full Text] [Related]  

  • 13. Lung disease due to alpha 1-antitrypsin deficiency.
    Wiedemann HP; Stoller JK
    Curr Opin Pulm Med; 1996 Mar; 2(2):155-60. PubMed ID: 9363132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lack of effect of substitution therapy of alpha1-antitrypsin deficiency].
    Dahl R; Hilberg O; Løkke A; Pedersen L; Ringbæk T; Titlestad I
    Ugeskr Laeger; 2011 Oct; 173(42):2645-7. PubMed ID: 22027165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency.
    Dirksen A; Piitulainen E; Parr DG; Deng C; Wencker M; Shaker SB; Stockley RA
    Eur Respir J; 2009 Jun; 33(6):1345-53. PubMed ID: 19196813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-1 antitrypsin: now available, but do we need it?
    Russi EW
    Swiss Med Wkly; 2008 Apr; 138(13-14):191-6. PubMed ID: 18389391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α1-Antitrypsin Deficiency.
    Hatipoğlu U; Stoller JK
    Clin Chest Med; 2016 Sep; 37(3):487-504. PubMed ID: 27514595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.
    Franciosi AN; McCarthy C; McElvaney NG
    Expert Rev Respir Med; 2015 Apr; 9(2):143-51. PubMed ID: 25598013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α1-Proteinase inhibitor (human) in the treatment of hereditary emphysema secondary to α1-antitrypsin deficiency: number and costs of years of life gained.
    Sclar DA; Evans MA; Robison LM; Skaer TL
    Clin Drug Investig; 2012 May; 32(5):353-60. PubMed ID: 22480280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term experience in the treatment of α1-antitrypsin deficiency: 25 years of augmentation therapy.
    Teschler H
    Eur Respir Rev; 2015 Mar; 24(135):46-51. PubMed ID: 25726554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.